Phase 4 Decompensated Heart Failure Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
The Effect of Dapagliflozin on Patients With Cardiomyopathy
Acute Decompensated Heart Failure (ADHF)
May Mohamed Abdalla100 enrolled1 locationNCT07076615
Recruiting
Phase 4
Combination Oral Acetazolamide and Intravenous Furosemide on Acute Decompensated Heart Failure Outcomes
Acute Decompensated Heart Failure
Universitas Diponegoro66 enrolled2 locationsNCT06475105
Recruiting
Phase 4
Efficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume Overload
EdemaAcute Decompensated Heart FailureVolume Overload
Cairo University110 enrolled1 locationNCT06414759
Recruiting
Phase 4
Colchicine in Acutely Decompensated HFREF
Heart FailureHeart Failure With Reduced Ejection FractionDecompensated Heart Failure
University of Virginia30 enrolled1 locationNCT06286423
Recruiting
Phase 4
Subcutaneous Frusemide in patients with heart failure
Decompensated Heart Failure
Auckland City Hospital20 enrolled1 locationACTRN12612000477820